Koers GlobeImmune Inc Nasdaq
Aandelen
US37957B1008
Biotechnologie & Medisch Onderzoek
Omzet 2014 | 5,97 mln. 5,56 mln. | Omzet 2015 | 6,46 mln. 6,01 mln. | Marktkapitalisatie | 22,26 mln. 20,73 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -16 mln. -14,9 mln. | Nettowinst (verlies) 2015 | -2 mln. -1,86 mln. | EV/omzet 2014 | 4,5 x |
Nettoliquiditeiten 2014 | 16,81 mln. 15,66 mln. | Nettoliquiditeiten 2015 | 9,9 mln. 9,22 mln. | EV/omzet 2015 | 1,91 x |
K/w-verhouding 2014 |
-0,94
x | K/w-verhouding 2015 |
-8,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Augustine Lawlor
BRD | Director/Board Member | 67 | 01-06-03 |
Ehud Geller
BRD | Director/Board Member | 77 | - |
Charles C. Kim
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,44% | 122 mld. | |
+18,94% | 113 mld. | |
+19,62% | 26,22 mld. | |
-25,37% | 19,01 mld. | |
-20,21% | 15,71 mld. | |
-20,20% | 15,22 mld. | |
-47,37% | 14,72 mld. | |
+59,91% | 14,58 mld. | |
+4,35% | 13,84 mld. |